secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2026-08-04T20:05:47+00:00
Accession:  0001493152-26-035993
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals gets Nasdaq bid-price extension to Feb 1, 2027; notes Nuclea Energy deal
--------------------------------------------------------------------------------

- Nasdaq granted 180-day extension until Feb 1, 2027 to meet $1 minimum bid price for 10 consecutive days.
- Company meets all other Nasdaq listing requirements except the bid price rule.
- Company may effect a reverse stock split if needed to cure the deficiency.
- Company continues to advance business combination with Nuclea Energy Inc. (Morpheus microreactor).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226035993/0001493152-26-035993-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226035993/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035993

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer